×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.

Become an Incathlab member and receive full access to its content!

You must be an Incathlab member to access videos without any restrictions. Register for free in one minute and access all services provided by Incathlab.You will also be able to log into Incathlab from your Facebook or twitter account by clicking on login on the top-right corner of Incathlab website.

Registration Login


20265 views


The treatment of Peripheral Artery Disease (PAD) has known an important evolution in the last years. An important limitation of current endovascular therapy remains the occurrence of restenosis. In order to minimize restenosis rates, Drug-Eluting Technologies (DET) are evolving. The use of drug-eluting stents (DES) in coronary arteries shows beneficial results, leading to investigation of DES in PAD.

In this web symposium, we give an overview of current available data on PAD treatment with drug eluting technologies.
Through video cases performed by expert operators, discover techniques and devices to improve the use of DET in your daily practice. 

Program

  • Debate with our experts : How Drug Eluting Technologies will revolutionize your practice?
  • 1st case : Calcified left SFA - Double access ( Antegrade + Retrograde)

  • How to use DET based on clinical data review in 2016? – Lecture by Dr Thomas Zeller
  • 2nd case : Polystenotic calcified right SFA Antegrade approach - DES and DEB combination therapy

  • Eluvia, designing a revolutionary drug eluting stent for SFA interventions – Lecture by Jaydeep Kokate
  • 3rd case : Short left superficial femoral artery Eluvia stenting

  • My experience in DET : indications and algorythm - Lecture by Dr Koen Deloose

Educational objectives

  • Discuss current trends and approaches to the treatment of PAD with the use of DET, in terms of patient’s outcomes
  • Demonstrate advanced techniques and new drug eluting technologies in the treatment of peripheral artery disease
  • Provide platform for discussion and mutual learning

Audience

  • Endovascular specialists (Vascular Surgeons, Interventional Radiologists, Interventional Angiologists and Interventional Cardiologists)
  • Referring physicians of patients with peripheral artery disease
Shooting date : 2016-07-13
Last update : 2021-06-09
Max Amor
Essey-lès-Nancy, France
Koen Deloose
Dendermonde, Belgium
Thomas Zeller
Bad Krozingen, Germany

Suggestions

January 2014
Honolulu : Monday, January 27th 2014 from 11pm to 12am (GMT+1)
San Francisco : Tuesday, January 28th 2014 from 01am to 02am (GMT+1)
New York : Tuesday, January 28th 2014 from 04am to 05am (GMT+1)
Buenos Aires : Tuesday, January 28th 2014 from 06am to 07am (GMT+1)
London / Dublin : Tuesday, January 28th 2014 from 09am to 10am (GMT+1)
Paris / Berlin : Tuesday, January 28th 2014 from 10am to 11am (GMT+1)
Istanbul : Tuesday, January 28th 2014 from 11am to 12pm (GMT+1)
Moscou / Dubaï : Tuesday, January 28th 2014 from 01pm to 02pm (GMT+1)
Bangkok : Tuesday, January 28th 2014 from 04pm to 05pm (GMT+1)
Shanghai : Tuesday, January 28th 2014 from 05pm to 06pm (GMT+1)
Tokyo : Tuesday, January 28th 2014 from 06pm to 07pm (GMT+1)
Sydney : Tuesday, January 28th 2014 from 07pm to 08pm (GMT+1)
Wellington : Tuesday, January 28th 2014 from 09pm to 10pm (GMT+1)

Electronic Endovascular Education Program: Treatment of the SFA

Live session from LINC congress, Leipzig - Germany

Share

Left iliac venous occlusion

Dr Black, Dr De Graaf, Dr Hartung & Dr O'Sullivan

Share
Scroll Up